Cargando…
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
To evaluate the safety and exploratory efficacy of intratympanic administration of OTO-313 in patients with tinnitus. STUDY DESIGN: Single intratympanic injection of OTO-313 evaluated in a randomized, double-blind, placebo-controlled Phase 1/2 clinical study. SETTING: Tertiary referral centers. PATI...
Autores principales: | Maxwell, Kenneth S., Robinson, James M., Hoffmann, Ines, Hou, Huiying J., Searchfield, Grant, Baguley, David M., McMurry, Gordon, Piu, Fabrice, Anderson, Jeffery J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584222/ https://www.ncbi.nlm.nih.gov/pubmed/34629442 http://dx.doi.org/10.1097/MAO.0000000000003369 |
Ejemplares similares
-
A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus
por: Searchfield, Grant D., et al.
Publicado: (2023) -
Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus
por: Staecker, Hinrich, et al.
Publicado: (2017) -
The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial
por: Bauer, Carol A., et al.
Publicado: (2017) -
Tinnitus characteristics in patients with idiopathic sudden sensorineural hearing loss and acute tinnitus
por: Mokhatrish, Mohammad, et al.
Publicado: (2023) -
Prevalence of Tinnitus in an Aging Population and Its Relation to Age and Hearing Loss
por: Oosterloo, Berthe C., et al.
Publicado: (2020)